Cytosorbents Financial Overview
Cytosorbents's market cap is currently $43.96M. The company's EPS TTM is $-0.04; its P/E ratio is -3.68; Cytosorbents is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
